Cargando…
The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is still one of the deadliest cancers in western countries. It is commonly diagnosed at advanced stages and most anti-cancer therapies have failed to substantially improve prognosis of PDAC patients. PDAC is characterized by a profound inflamma...
Autores principales: | Wandmacher, Anna Maxi, Mehdorn, Anne-Sophie, Sebens, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508450/ https://www.ncbi.nlm.nih.gov/pubmed/34638420 http://dx.doi.org/10.3390/cancers13194932 |
Ejemplares similares
-
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer
por: Wandmacher, Anna Maxi, et al.
Publicado: (2021) -
The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
por: Kayser, Charlotte, et al.
Publicado: (2023) -
Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma
por: Daunke, Tina, et al.
Publicado: (2023) -
Interaction of tumor cells with the microenvironment
por: Ungefroren, Hendrik, et al.
Publicado: (2011) -
The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer
por: Basu, Meghna, et al.
Publicado: (2021)